Anshan Hifichem Co., Ltd.

SZSE:300758 Stok Raporu

Piyasa değeri: CN¥5.2b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Anshan Hifichem Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anshan Hifichem has a total shareholder equity of CN¥1.8B and total debt of CN¥871.4M, which brings its debt-to-equity ratio to 47.5%. Its total assets and total liabilities are CN¥3.6B and CN¥1.8B respectively. Anshan Hifichem's EBIT is CN¥130.5M making its interest coverage ratio 4.4. It has cash and short-term investments of CN¥336.7M.

Anahtar bilgiler

47.5%

Borç/özkaynak oranı

CN¥871.37m

Borç

Faiz karşılama oranı4.4x
NakitCN¥336.73m
EşitlikCN¥1.84b
Toplam yükümlülüklerCN¥1.77b
Toplam varlıklarCN¥3.61b

Son finansal sağlık güncellemeleri

Recent updates

Why Investors Shouldn't Be Surprised By Anshan Hifichem Co., Ltd.'s (SZSE:300758) 27% Share Price Surge

Oct 01
Why Investors Shouldn't Be Surprised By Anshan Hifichem Co., Ltd.'s (SZSE:300758) 27% Share Price Surge

Anshan Hifichem (SZSE:300758) Has A Somewhat Strained Balance Sheet

Jul 26
Anshan Hifichem (SZSE:300758) Has A Somewhat Strained Balance Sheet

There's Reason For Concern Over Anshan Hifichem Co., Ltd.'s (SZSE:300758) Massive 30% Price Jump

May 27
There's Reason For Concern Over Anshan Hifichem Co., Ltd.'s (SZSE:300758) Massive 30% Price Jump

Anshan Hifichem (SZSE:300758) Could Be Struggling To Allocate Capital

May 06
Anshan Hifichem (SZSE:300758) Could Be Struggling To Allocate Capital

With Anshan Hifichem Co., Ltd. (SZSE:300758) It Looks Like You'll Get What You Pay For

Feb 28
With Anshan Hifichem Co., Ltd. (SZSE:300758) It Looks Like You'll Get What You Pay For

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 300758's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥900.6M).

Uzun Vadeli Yükümlülükler: 300758's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥868.8M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 300758 'nin net borç/özsermaye oranı ( 36.1% ) tatmin edici olarak kabul edilir.

Borcun Azaltılması: 300758's debt to equity ratio has increased from 7.2% to 47.5% over the past 5 years.

Borç Kapsamı: 300758's debt is not well covered by operating cash flow (9.9%).

Faiz Kapsamı: 300758's interest payments on its debt are well covered by EBIT (4.4x coverage).


Bilanço


Sağlıklı şirketleri keşfedin